Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$44.63 USD
+0.18 (0.40%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $44.62 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Balance Sheet
Fiscal Year End for Tandem Diabetes Care, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 468 | 617 | 624 | 485 | 176 |
Receivables | 106 | 115 | 111 | 82 | 47 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 158 | 111 | 69 | 64 | 49 |
Other Current Assets | 17 | 7 | 8 | 6 | 4 |
Total Current Assets | 748 | 850 | 812 | 637 | 276 |
Net Property & Equipment | 77 | 69 | 50 | 50 | 33 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 40 | 24 | 16 | 9 | 1 |
Total Assets | 953 | 1,053 | 905 | 716 | 326 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 50 | 56 | 28 | 18 | 18 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 56 | 48 | 61 | 39 | 36 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 72 | 48 | 34 | 38 | 39 |
Total Current Liabilities | 195 | 165 | 132 | 104 | 99 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 13 | 17 | 0 | 0 | 0 |
Convertible Debt | 285 | 283 | 281 | 203 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 32 | 24 | 35 | 27 | 18 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 639 | 613 | 472 | 350 | 131 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,264 | 1,171 | 1,068 | 1,025 | 820 |
Retained Earnings | -952 | -729 | -635 | -659 | -625 |
Other Equity | 1 | -2 | -1 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 314 | 440 | 433 | 366 | 195 |
Total Liabilities & Shareholder's Equity | 953 | 1,053 | 905 | 716 | 326 |
Total Common Equity | 314 | 440 | 433 | 366 | 195 |
Shares Outstanding | 65.20 | 64.30 | 63.50 | 60.90 | 59.00 |
Book Value Per Share | 4.81 | 6.84 | 6.82 | 6.01 | 3.30 |
Fiscal Year End for Tandem Diabetes Care, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 452 | 468 | 468 | 498 | 507 |
Receivables | 98 | 93 | 106 | 100 | 99 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 162 | 154 | 158 | 143 | 148 |
Other Current Assets | 21 | 21 | 17 | 16 | 11 |
Total Current Assets | 733 | 735 | 748 | 758 | 764 |
Net Property & Equipment | 79 | 78 | 77 | 76 | 74 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 37 | 40 | 40 | 17 | 18 |
Total Assets | 938 | 941 | 953 | 940 | 947 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 41 | 0 | 0 | 0 | 0 |
Accounts Payable | 48 | 48 | 50 | 46 | 57 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 56 | 53 | 56 | 58 | 49 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 78 | 75 | 72 | 66 | 51 |
Total Current Liabilities | 241 | 193 | 195 | 187 | 175 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 12 | 12 | 13 | 14 | 15 |
Convertible Debt | 307 | 348 | 285 | 285 | 284 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 33 | 32 | 24 | 25 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 704 | 698 | 639 | 626 | 617 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 1,260 | 1,238 | 1,264 | 1,238 | 1,219 |
Retained Earnings | -1,025 | -995 | -952 | -922 | -889 |
Other Equity | -1 | -1 | 1 | -2 | -1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 234 | 243 | 314 | 314 | 329 |
Total Liabilities & Shareholder's Equity | 938 | 941 | 953 | 940 | 947 |
Total Common Equity | 234 | 243 | 314 | 314 | 329 |
Shares Outstanding | 65.40 | 64.50 | 65.20 | 65.20 | 65.00 |
Book Value Per Share | 3.58 | 3.77 | 4.81 | 4.82 | 5.07 |